Hanson & Doremus Investment Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $68K | Hold |
653
| – | – | 0.01% | 304 |
|
|
2026
Q1 | $47K | Hold |
653
| – | – | 0.01% | 339 |
|
|
2025
Q4 | $52K | Hold |
653
| – | – | 0.01% | 318 |
|
|
2025
Q3 | $49K | Buy |
653
+153
| +31% | +$10.5K | 0.01% | 327 |
|
|
2025
Q2 | $34K | Sell |
500
-1,000
| -67% | -$65.6K | ﹤0.01% | 356 |
|
|
2025
Q1 | $102K | Buy |
+1,500
| New | +$89.8K | 0.01% | 254 |
|
|
2024
Q3 | – | Sell |
-340
| Closed | -$20K | – | 426 |
|
|
2024
Q2 | $20K | Sell |
340
-4,169
| -92% | -$261K | ﹤0.01% | 368 |
|
|
2024
Q1 | $360K | Sell |
4,509
-753
| -14% | -$57.5K | 0.06% | 133 |
|
|
2023
Q4 | $415K | Sell |
5,262
-2,482
| -32% | -$177K | 0.08% | 122 |
|
|
2023
Q3 | $541K | Sell |
7,744
-18,798
| -71% | -$1.33M | 0.11% | 105 |
|
|
2023
Q2 | $1.83M | Buy |
26,542
+3,849
| +17% | +$274K | 0.38% | 56 |
|
|
2023
Q1 | $1.69M | Sell |
22,693
-2,159
| -9% | -$181K | 0.37% | 58 |
|
|
2022
Q4 | $2.32M | Buy |
24,852
+4,328
| +21% | +$418K | 0.5% | 46 |
|
|
2022
Q3 | $1.96M | Buy |
20,524
+573
| +3% | +$56.7K | 0.51% | 44 |
|
|
2022
Q2 | $1.85M | Buy |
19,951
+949
| +5% | +$92.6K | 0.45% | 45 |
|
|
2022
Q1 | $1.92M | Buy |
19,002
+157
| +0.8% | +$16.5K | 0.41% | 48 |
|
|
2021
Q4 | $1.94M | Buy |
18,845
+678
| +4% | +$62.7K | 0.42% | 48 |
|
|
2021
Q3 | $1.54M | Buy |
18,167
+3,449
| +23% | +$289K | 0.36% | 53 |
|
|
2021
Q2 | $860K | Sell |
14,718
-4,270
| -22% | -$350K | 0.26% | 78 |
|
|
2021
Q1 | $1.43M | Buy |
18,988
+2,413
| +15% | +$176K | 0.33% | 62 |
|
|
2020
Q4 | $1.13M | Buy |
16,575
+1,857
| +13% | +$121K | 0.28% | 72 |
|
|
2020
Q3 | $860K | Buy |
14,718
+1,612
| +12% | +$100K | 0.26% | 78 |
|
|
2020
Q2 | $851K | Sell |
13,106
-835
| -6% | -$52.6K | 0.27% | 76 |
|
|
2020
Q1 | $827K | Buy |
13,941
+1,783
| +15% | +$119K | 0.28% | 73 |
|
|
2019
Q4 | $903K | Buy |
12,158
+425
| +4% | +$29.8K | 0.26% | 82 |
|
|
2019
Q3 | $740K | Buy |
11,733
+2,619
| +29% | +$155K | 0.23% | 90 |
|
|
2019
Q2 | $497K | Buy |
9,114
+2,257
| +33% | +$122K | 0.16% | 109 |
|
|
2019
Q1 | $370K | Sell |
6,857
-219
| -3% | -$13.5K | 0.12% | 129 |
|
|
2018
Q4 | $464K | Buy |
7,076
+1,144
| +19% | +$85.4K | 0.17% | 109 |
|
|
2018
Q3 | $467K | Buy |
5,932
+4,321
| +268% | +$309K | 0.15% | 119 |
|
|
2018
Q2 | $104K | Buy |
1,611
+97
| +6% | +$6.39K | 0.03% | 227 |
|
|
2018
Q1 | $94K | Buy |
1,514
+130
| +9% | +$9.33K | 0.03% | 246 |
|
|
2017
Q4 | $100K | Buy |
1,384
+63
| +5% | +$4.58K | 0.03% | 237 |
|
|
2017
Q3 | $107K | Buy |
1,321
+19
| +1% | +$1.5K | 0.04% | 222 |
|
|
2017
Q2 | $105K | Buy |
1,302
+402
| +45% | +$31.7K | 0.04% | 217 |
|
|
2017
Q1 | $71K | Buy |
900
+700
| +350% | +$55.9K | 0.03% | 247 |
|
|
2016
Q4 | $15.8K | Hold |
200
| – | – | 0.01% | 352 |
|
|
2016
Q3 | $18K | Hold |
200
| – | – | 0.01% | 328 |
|
|
2016
Q2 | $19K | Hold |
200
| – | – | 0.01% | 311 |
|
|
2016
Q1 | $21K | Hold |
200
| – | – | 0.01% | 308 |
|
|
2015
Q4 | $20K | Hold |
200
| – | – | 0.01% | 335 |
|
|
2015
Q3 | $19K | Hold |
200
| – | – | 0.01% | 321 |
|
|
2015
Q2 | $21K | Hold |
200
| – | – | 0.01% | 327 |
|
|
2015
Q1 | $21K | Hold |
200
| – | – | 0.01% | 329 |
|
|
2014
Q4 | $19K | Hold |
200
| – | – | 0.01% | 336 |
|
|
2014
Q3 | $16K | Buy |
+200
| New | +$15.8K | 0.01% | 331 |
|
Other funds holding CVS
Hanson & Doremus Investment Management's CVS Position: Q2 2026 in Review
Hanson & Doremus Investment Management held its CVS Health (CVS) position steady in Q2 2026 at 653 shares worth $68K. The position accounts for 0.01% of the portfolio, ranked #304.
Hanson & Doremus Investment Management first reported a position in CVS in Q3 2014 and has held it in 46 quarters since. The position peaked at $2.32M in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Hanson & Doremus Investment Management held 653 shares of CVS Health worth $68K as of Q2 2026.
- Hanson & Doremus Investment Management left its CVS Health share count unchanged in Q2 2026.
- CVS Health made up 0.01% of Hanson & Doremus Investment Management's portfolio in Q2 2026, its #304 holding.
- Hanson & Doremus Investment Management first reported a position in CVS Health in Q3 2014 and has held it in 46 quarters since.
- Hanson & Doremus Investment Management's CVS Health position peaked at $2.32M in Q4 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Hanson & Doremus Investment Management's 13F filing for Q2 2026, filed 29 Jul 2026.